Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do different atrial flutter types carry the same thromboembolic risk?

Ahmet Duran Demir1, Mustafa Soylu, Ozcan Ozdemir

  • 1Department of Cardiology at Türkiye Yüksek Ihtisas Hospital, Ankara, Turkey. demirad@ixir.com

Angiology
|September 30, 2005
PubMed
Summary

Atypical atrial flutter (AFl) shows increased coagulation activity, suggesting a higher thromboembolic risk. Anticoagulation therapy should be considered for patients with atypical AFl to mitigate this risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between ambulatory arterial stiffness ındex and SCORE-derived vascular age in ındividuals without cardiovascular disease.

Kardiologia polska·2026
Same author

Different Responses to Premature Atrial Complexes During Wide QRS Complex Tachycardia: What Is the Mechanism?

The Journal of innovations in cardiac rhythm management·2026
Same author

Termination of Ventricular Tachycardia by Prepotential Exit Block.

The Journal of innovations in cardiac rhythm management·2026
Same author

Reply to the Letter to the Editor: 'Albumin as a Pharmacokinetic Confound and the Temporal Validity of the MAPH Score in Atrial Fibrillation'.

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir·2026
Same author

Additional Stroke Risk Factors Beyond the CHA<sub>2</sub>DS<sub>2</sub>-VA Score in Non-Valvular Atrial Fibrillation: An Interdisciplinary Expert Opinion.

Journal of clinical medicine·2026
Same author

A Mid-Tracing Mystery During Narrow QRS Complex Tachycardia: What Is the Mechanism?

Pacing and clinical electrophysiology : PACE·2026

Area of Science:

  • Cardiology
  • Hematology
  • Thrombosis

Background:

  • Thromboembolic risk varies among atrial flutter (AFl) types.
  • Previous studies have not sufficiently clarified these differences.

Purpose of the Study:

  • To compare thromboembolic risk factors between typical and atypical atrial flutter (AFl).
  • To evaluate clinical, echocardiographic, and hematologic parameters in AFl subtypes.

Main Methods:

  • Patients were classified into typical AFl and atypical AFl groups based on ECG and electrophysiologic characteristics.
  • A control group without heart disease in sinus rhythm was included.
  • Clinical, echocardiographic, and hematologic parameters, including coagulation markers, were assessed.

Main Results:

Related Experiment Videos

  • No significant differences in clinical or echocardiographic parameters were observed between typical and atypical AFl groups.
  • Hematologic markers of coagulation activity (fibrinogen, D-dimer, thrombin-antithrombin III) were significantly elevated in atypical AFl patients compared to typical AFl and controls.
  • No correlation was found between elevated hematologic markers and clinical or echocardiographic findings.

Conclusions:

  • Atypical atrial flutter (AFl) is associated with heightened coagulation system activity.
  • Patients with atypical AFl exhibit an increased thromboembolic risk.
  • Anticoagulation should be considered for patients diagnosed with atypical AFl.